TickerFactsScreenerDevelopers

Autolus Therapeutics plc (AUTL) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$23.42M2018: -$57.53M2019: -$146.06M2020: -$168.15M2021: -$141.05M2022: -$143.41M2023: -$179.70M2024: -$241.43M2025: -$270.54M-$270.54M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$270.54M-12.1%
2024-$241.43M-34.3%
2023-$179.70M-25.3%
2022-$143.41M-1.7%
2021-$141.05M+16.1%
2020-$168.15M-15.1%
2019-$146.06M-153.9%
2018-$57.53M-145.7%
2017-$23.42M—